PUBBLICAZIONI SCIENTIFICHE
De Amicis R., Leone A., Lessa C., Foppiani A., Ravella S., Ravasenghi S., Trentani C., Ferraris C., Veggiotti P., De Giorgis V., Tagliabue A., Battezzati A., Bertoli A. Long-term effect of classic ketogenic diet on ghrelin and leptin concentration: a 12-months prospective study in a cohort of Italian children and adults with GLUT1-Deficiency Syndrome and drug resistant epilepsy. Nutrients 2019
Varesio C, Pasca L, Parravicini S, Zanaboni MP, Ballante E, Masnada S, Ferraris C, Bertoli S, Tagliabue A, Veggiotti P, De Giorgis V. Quality of life in chronic ketogenic diet treatment: the GLUT1DS population perspective. Nutrients 2019, 11(7), 1650
Ferraris C, Guglielmetti M, Pasca L, De Giorgis V, Ferraro OE, Brambilla I, Leone A, De Amicis R, Bertoli S, Veggiotti P, Tagliabue A. Impact of the Ketogenic Diet on Linear Growth in Children: A Single-Center Retrospective Analysis of 34 Cases. Nutrients 2019, 11(7), 1442
Leone A, De Amicis R, Lessa C, Tagliabue A, Trentani C, Ferraris C, Battezzati A, Veggiotti P, Foppiani A, Ravella S, Bertoli S. Food and Food Products on the Italian Market for Ketogenic Dietary Treatment of Neurological Diseases (Review). Nutrients 2019: 11 (5), 1104
De Giorgis V, Masnada S, Varesio C, Chiappedi MA, Zanaboni M, Pasca L, Filippini M, Macasaet JA, Valente M, Ferraris C, Tagliabue A, Veggiotti P. Overall cognitive profiles in patients with GLUT1 Deficiency Syndrome. Brain and Behavior 2019: 9 (3)
Zini EM, Tagliabue A, Trentani C, Ferraris C, Boninsegna R, Quaglini S, Lanzola G.An mHealth Application for Educating and Monitoring Patients Treated with a Ketogenic Diet Regimen. Stud Health Technol Inform. 2018;247:481-485.
Pasca L, Caraballo RH, De Giorgis V, Reyes JG, Macasaet JA, Masnada S, Armeno M, Musicco M, Tagliabue A, Veggiotti P.Ketogenic diet use in children with intractable epilepsy secondary to malformations of cortical development: A two- centre experience. Seizure. 2018 Apr;57:34-37. doi: 10.1016/j.seizure.2018.03.005.
Tagliabue A, Ferraris C, Uggeri F, Trentani C, Bertoli S, De Giorgis V, Veggiotti P, Elli M: Short-term impact of a classical ketogenic diet on gut microbiota in GLUT1 deficiency syndrome: A 3-month prospective observational study. Clinical Nutrition ESPEN 17 (2017) 33-37.
Pasca L, De Giorgis V, Macasaet JA, Trentani C, Tagliabue A, Veggiotti P. The changing face of dietary therapy for epilepsy. Eur J Pediatr 2016 (IF 1,921) 175:1267–1276 doi10.1007/s00431-016-2765-z
De Giorgis V, Teutonico F, Cereda C, Balottin U, Bianchi M, Giordano L, Olivotto S, Ragona F, Tagliabue A, Zorzi G, Nardocci N, Veggiotti P. Sporadic and familial glut1ds Italian patients: A wide clinical variability. Seizure 2015 (IF 2,059) 24:28-32. doi: 0.1016/j.seizure.2014.11.009.
Morandi G, Guido D, Tagliabue A. A bibliometric study of scientific literature on the dietary therapies for epilepsy in Scopus. Nutritional Neuroscience 2015 (IF 2,616) 18 (5): 201-9. doi: 10.1179/1476830514Y.0000000118.
Bertoli S, Battezzati A, Tagliabue A. Ketogenic diet in children with intractable epilepsy: what about resting energy expenditure and growth? Dev Med Child Neurol 2014 (IF 3,510) 56 (9):806-7. doi: 10.1111/dmcn.12474.
Bertoli S, Trentani C, Ferraris C, de Giorgis V, Veggiotti P, Tagliabue A. Long-term effect of a ketogenic diet on body compositon and bone mineralizarion in GLUT-1 deficiency syndrome: a case series. Nutrition 2014 (IF 2,926)(6):726-8. doi: 10.1016/j.nut.2014.01.005.
Tagliabue A, Bertoli S, Trentani C, Borrelli P, Veggiotti P.”Effects of the ketogenic diet on nutritional status, resting energy expenditure, and substrate oxidation in patients with medically refractory epilepsy: A 6-month prospective observational study”. Clinical Nutrition 2012 (IF 3,298) 31:246-249.
Veggiotti P, Burlina A, Coppola G, Cusmai R, De Giorgis V, Guerrini R, Tagliabue A and Dalla Bernardina B. “ The ketogenic diet for Dravet syndrome and other epileptic encephalopathies: An Italian consensus” Epilepsia, 2011 (IF 3,961) 52 (Suppl. 2):83–89.
Veggiotti P, Teutonico F, Alfei E, Nardocci N, Zorzi G, Tagliabue A, De Giorgis V, Balottin U. “Glucose transporter type 1 deficiency: ketogenic diet in three patients with atypical phenotype”. Brain Dev. 2010 (IF 1,743) 32 (5):404-8.
Bertoli S, Cardinali S, Veggiotti P, Trentini C, Testolin G, Tagliabue A. Evaluation of nutritional status in children with refractory epilepsy. Nutrition Journal 2006 (IF 2,56) 5 (1):14.
Cardinali S, Canafoglia L, Bertoli S, Franceschetti S, Lanzi G, Tagliabue A, Veggiotti P. A pilot study of a ketogenic diet in patients with Lafora body disease. Epilepsy Research 2006 (IF 2,1) vol 69: 129 – 134.
Freeman J., Veggiotti P., Lanzi G., Tagliabue A., and Perucca E. The Ketogenic diet: from molecular mechanisms to clinical effects. Epilepsy Research 2006 (IF 2,088)Vol 68: 145-180.
Bertoli S, Cardinali S, Veggiotti P, Tagliabue A. Nutritional and pharmacological management of childhood epilepsy: ketogenic diets and common AEDs. Current Medicinal Chemistry – Immunology., Endocrine and Metabolic Agents 2005 (IF 4.382) 5(2)113-123.
Granocchio E, Cardinali S, Longaretti F, Faggio A, Franceschetti S, Canafoglia L, Tagliabue A, Viri M, Lodi M, Termine C, Zoppello M, Veggiotti P. Neuropsychological follow-up in 5 patients with Lafora’s disease treated with ketogenic diet [Follow-up neuropsicologico in 5 pazienti con malattia di Lafora in terapia con dieta chetogenica] Bollettino – Lega Italiana contro l’Epilessia 2004
Coppola G, Veggiotti P, Cusmai R, Bertoli S, Cardinali S, Distinto I, Elia M, Lispi ML, Sarnelli C, Tagliabue A, Dionisi-Vici C, Pascotto A. “The ketogenic diet in children, adolescents and young adults with refractory epilepsy: an italian multicentric experience” Epilepsy Research 2002 (IF 2.355) 48 (3): 221-227.
Cusmai R. Lispi ML, Veggiotti P, Resi C, Cardinali S, Bertoli S, Tagliabue A. Ketogenic diet in farmacoresistant epilecties. Bollettino-Lega Italiana Contro L’Epilessia,106, 365-7,1999
Veggiotti P, Resi C, Cardinali S, Bertoli S, Tagliabue A, Trentani C, Lanzola E and Lanzi G. “La dieta chetogenica nel trattamento dell’ epilessia farmaco-resistente. Studio pilota di 10 pazienti.” Rivista Italiana di Pediatria 1999; 25: 883-889.
Resi C, Bertoli S, Tagliabue A, Trentani C, Granocchio E, Cardinali S, Veggiotti P. “Utilizzo della dieta chetogenica nell’epilessia farmacoresistente: dati preliminari. Bollettino della Lega Italiana contro l’ Epilessia 102/103: 191-192, 1998.
Tagliabue A, Bertoli S, Trentani C, Lanzola E, Veggiotti P, Lanzi G. “Epilessia farmaco-resistente trattata con dieta chetogenica” Recenti Progressi in Medicina, , vol 88: 77 -79, 1997.
